Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.

Ribeiro A, Laranjeira P, Mendes S, Velada I, Leite C, Andrade P, Santos F, Henriques A, Grãos M, Cardoso CM, Martinho A, Pais M, da Silva CL, Cabral J, Trindade H, Paiva A.

Stem Cell Res Ther. 2013 Oct 15;4(5):125. doi: 10.1186/scrt336.

2.

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.

Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F.

Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216.

3.

Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.

Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, Ribeiro T, Santos F, Trindade H, Paiva A.

Stem Cell Res Ther. 2015 Jan 5;6:3. doi: 10.1186/scrt537.

4.

Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.

Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z.

Hum Vaccin Immunother. 2016;12(1):85-96. doi: 10.1080/21645515.2015.1030549.

5.

Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.

Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Weimar W, Hoogduijn MJ.

Stem Cells Dev. 2010 Dec;19(12):1843-53. doi: 10.1089/scd.2009.0368.

PMID:
20367242
6.

Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.

Lin R, Ma H, Ding Z, Shi W, Qian W, Song J, Hou X.

Stem Cells Dev. 2013 Nov 1;22(21):2836-48. doi: 10.1089/scd.2013.0166.

PMID:
23777268
8.

A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M.

Immunology. 2011 Nov;134(3):326-40. doi: 10.1111/j.1365-2567.2011.03493.x.

9.

An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells.

Martin JF, Perry JS, Jakhete NR, Wang X, Bielekova B.

J Immunol. 2010 Jul 15;185(2):1311-20. doi: 10.4049/jimmunol.0902238.

10.

Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.

Blanco B, Herrero-Sánchez MD, Rodríguez-Serrano C, García-Martínez ML, Blanco JF, Muntión S, García-Arranz M, Sánchez-Guijo F, Del Cañizo C.

Eur J Haematol. 2016 Dec;97(6):528-537. doi: 10.1111/ejh.12765.

PMID:
27118602
11.

Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.

Li Y, Qu YH, Wu YF, Liu L, Lin XH, Huang K, Wei J.

Cell Biol Int. 2015 Apr;39(4):435-45. doi: 10.1002/cbin.10404.

PMID:
25492047
12.

Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.

Najar M, Raicevic G, Boufker HI, Fayyad-Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.

Tissue Eng Part A. 2010 Nov;16(11):3537-46. doi: 10.1089/ten.TEA.2010.0159.

PMID:
20597819
13.

Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.

Hoogduijn MJ, Roemeling-van Rhijn M, Korevaar SS, Engela AU, Weimar W, Baan CC.

Hum Gene Ther. 2011 Dec;22(12):1587-91. doi: 10.1089/hum.2011.039.

PMID:
21732766
14.

Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.

Kim HS, Shin TH, Lee BC, Yu KR, Seo Y, Lee S, Seo MS, Hong IS, Choi SW, Seo KW, Núñez G, Park JH, Kang KS.

Gastroenterology. 2013 Dec;145(6):1392-403.e1-8. doi: 10.1053/j.gastro.2013.08.033.

PMID:
23973922
15.

Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.

Cui R, Rekasi H, Hepner-Schefczyk M, Fessmann K, Petri RM, Bruderek K, Brandau S, Jäger M, Flohé SB.

Stem Cell Res Ther. 2016 Jul 7;7(1):88. doi: 10.1186/s13287-016-0353-9.

16.

IFN-γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro.

Noone C, Kihm A, English K, O'Dea S, Mahon BP.

Stem Cells Dev. 2013 Nov 15;22(22):3003-14. doi: 10.1089/scd.2013.0028.

17.

Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.

Ozerol I, Ageitos A, Heimann DG, Talmadge JE.

Int J Immunopharmacol. 1999 Aug;21(8):509-21.

PMID:
10458540
18.

Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.

Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I, Tivchev P, Kyurkchiev S.

Cell Biol Int. 2008 Apr;32(4):384-93. doi: 10.1016/j.cellbi.2007.12.007.

PMID:
18262807
19.

Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.

Carrade Holt DD, Wood JA, Granick JL, Walker NJ, Clark KC, Borjesson DL.

Stem Cells Dev. 2014 Jun 1;23(11):1258-65. doi: 10.1089/scd.2013.0537.

PMID:
24438346
20.

An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.

Chao YH, Wu HP, Wu KH, Tsai YG, Peng CT, Lin KC, Chao WR, Lee MS, Fu YC.

PLoS One. 2014 Oct 22;9(10):e110338. doi: 10.1371/journal.pone.0110338.

Supplemental Content

Support Center